Try our Advanced Search for more refined results

Second NJ Trial Underway In Novartis Bone Drug Litigation

By Martin Bricketto (April 26, 2013, 9:54 PM EDT) -- Novartis Pharmaceuticals Corp. failed to adequately warn cancer doctors that its bone drug Zometa could cause osteonecrosis in patients' jaws, despite ample links between the medication and bone death, attorneys for a woman suing Novartis contended Friday in the second trial for the New Jersey mass tort litigation....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections

Law Firms

Companies

Government Agencies

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!